Clinical Trial: A Study of Minirin Melt in Patients With Nocturia

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Minirin Melt Tolerance With Nocturia in the Common Practice Conditions in Czech Republic

Brief Summary: This is a confirmation of safety profile for Minirin Melt in clinical practice.

Detailed Summary:
Sponsor: Ferring Pharmaceuticals

Current Primary Outcome: Verify the safety profile [ Time Frame: 12 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Safety aspect of dosage [ Time Frame: 12 months ]

Original Secondary Outcome: Same as current

Information By: Ferring Pharmaceuticals

Dates:
Date Received: October 5, 2010
Date Started: September 2008
Date Completion:
Last Updated: January 3, 2014
Last Verified: January 2014